Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATY
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
On May 20, 2021, Pfizer and BioNTech announced an agreement with Turkeyメs Ministry of Health to supply 60…
On May 19, 2021, APEIRON Biologics announced the next development steps for APN01 (alunacedase alfa) for the treatment…
On May 18, 2021, GlaxoSmithKline and Medicago reported positive interim Phase 2 clinical trial safety and immunogenicity data…
On May 17, 2021, Oxford University and Oracle announced they had created a Global Pathogen Analysis System combining…
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
On May 13, 2021, CureVac announced together with its collaboration partner GSK, first preclinical data in a rat…
On May 12, 2021, Moderna announced a new supply agreement with the government of Australia for 25 million…
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
On May 12, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On May 12, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On May 10, 2021, Novavax announced data from a preclinical study of the company’s combination quadrivalent seasonal flu…
On May 10, 2021, Cerecor announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
On May 10, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…
On May 7, 2021, the World Health Organization (WHO) listed the Sinopharm COVID-19 vaccine for emergency use, giving…
On May 7, 2021, Pfizer and BioNTech announced the initiation of a Biologics License Application (BLA) with the…
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
On May 6, 2021, Moderna announced a new supply agreement with the Swiss Federal Government for 7 million…
On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…
On May 6, 2021, Trevena announced that TRV027, the Companyメs novel AT1 receptor selective agonist, had been selected…
On May 5, 2021, the United States sent its first flight loaded with oxygen cylinders and regulators, N95…
On May 5, 2021, Humanigen announced that results from the lenzilumab Phase 3 study in hospitalized COVID-19 patients…
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…
On May 5, 2021, Pfizer and BioNTech announced that Health Canada had expanded the Interim Order authorization for…
On May 5, 2021, Hoth Therapeutics announced it has expanded its sponsored research agreement with Virginia Commonwealth University…
On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…
On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…
On May 3, 2021, the World Health Organization (WHO) welcomed the Government of Swedenメs announcement to share 1…